Cargando…
Cancer vaccines
Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical develo...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190070/ https://www.ncbi.nlm.nih.gov/pubmed/35700704 http://dx.doi.org/10.1016/j.ccell.2022.05.015 |
| _version_ | 1784725717700837376 |
|---|---|
| author | Schiller, John T. Lowy, Douglas R. Frazer, Ian H. Finn, Olivera J. Vilar, Eduardo Lyerly, H. Kim Gnjatic, Sacha Zaidi, Neeha Ott, Patrick A. Balachandran, Vinod P. Dietrich, Pierre-Yves Migliorini, Denis Vonderheide, Robert H. Domchek, Susan M. |
| author_facet | Schiller, John T. Lowy, Douglas R. Frazer, Ian H. Finn, Olivera J. Vilar, Eduardo Lyerly, H. Kim Gnjatic, Sacha Zaidi, Neeha Ott, Patrick A. Balachandran, Vinod P. Dietrich, Pierre-Yves Migliorini, Denis Vonderheide, Robert H. Domchek, Susan M. |
| author_sort | Schiller, John T. |
| collection | PubMed |
| description | Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation. |
| format | Online Article Text |
| id | pubmed-9190070 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91900702022-06-13 Cancer vaccines Schiller, John T. Lowy, Douglas R. Frazer, Ian H. Finn, Olivera J. Vilar, Eduardo Lyerly, H. Kim Gnjatic, Sacha Zaidi, Neeha Ott, Patrick A. Balachandran, Vinod P. Dietrich, Pierre-Yves Migliorini, Denis Vonderheide, Robert H. Domchek, Susan M. Cancer Cell Voices Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation. Elsevier Inc. 2022-06-13 2022-06-13 /pmc/articles/PMC9190070/ /pubmed/35700704 http://dx.doi.org/10.1016/j.ccell.2022.05.015 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Voices Schiller, John T. Lowy, Douglas R. Frazer, Ian H. Finn, Olivera J. Vilar, Eduardo Lyerly, H. Kim Gnjatic, Sacha Zaidi, Neeha Ott, Patrick A. Balachandran, Vinod P. Dietrich, Pierre-Yves Migliorini, Denis Vonderheide, Robert H. Domchek, Susan M. Cancer vaccines |
| title | Cancer vaccines |
| title_full | Cancer vaccines |
| title_fullStr | Cancer vaccines |
| title_full_unstemmed | Cancer vaccines |
| title_short | Cancer vaccines |
| title_sort | cancer vaccines |
| topic | Voices |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190070/ https://www.ncbi.nlm.nih.gov/pubmed/35700704 http://dx.doi.org/10.1016/j.ccell.2022.05.015 |
| work_keys_str_mv | AT schillerjohnt cancervaccines AT lowydouglasr cancervaccines AT frazerianh cancervaccines AT finnoliveraj cancervaccines AT vilareduardo cancervaccines AT lyerlyhkim cancervaccines AT gnjaticsacha cancervaccines AT zaidineeha cancervaccines AT ottpatricka cancervaccines AT balachandranvinodp cancervaccines AT dietrichpierreyves cancervaccines AT migliorinidenis cancervaccines AT vonderheideroberth cancervaccines AT domcheksusanm cancervaccines |